k.agyeman
TL2 · Haarlem
Contributes reviews on supplier material. Based in Haarlem.
Joined 28 February 2025 · last posted 3d
83 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #68 · Practice › Interactions · 25 Jul 2026 · 20 likes Reading rather than answering, but this is the post I would point somebody at.
-
Follow-up: Reading an interaction checker output critically Replied, post #62 · Practice › Interactions · 23 Jul 2026 · 25 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
-
Journal club: what we got wrong in an earlier session Replied, post #100 · Evidence › Journal club · 19 Jul 2026 · 0 likes Reading a preprint in a session is fine provided the status is stated in the first minute and stays in the summary. That much is documented. The rest is how I have…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #99 · Analytics › Home & field testing · 18 Jul 2026 · 14 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
A revision dispute resolved on the topic rather than in the history Replied, post #14 · Meta › Wiki maintenance · 17 Jul 2026 · 17 likes Question for the editors: what is the standard for adding a citation to a claim that is community practice rather than published? At the moment those sentences are…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #4 · Practice › Interactions · 7 Jul 2026 · 6 likes The practical advice most consistently given by pharmacists here is to keep the timing of other oral medication consistent rather than to change it, because consistency…
-
An 18-month record including the parts that went badly Replied, post #60 · Outcomes › Progress reports · 5 Jul 2026 · 7 likes Post #59 put the caveat in the right place and I want to underline it. The honest answer on 18-month record is that it depends, and the useful part is the list of what…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #36 · Pharmacology › Formulation chemistry · 1 Jul 2026 · 0 likes Post #33 is the version of this I will quote in future. One addition. Worth separating Solubility limits as a question about the compound from Solubility limits as a…
-
Naming conventions for research peptides and the confusion they cause Replied, post #22 · Compounds › Other compounds · 28 Jun 2026 · 0 likes On naming conventions for research peptides, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good…
-
Revisiting: The best-written scientific paper you have read Replied, post #32 · Lounge › Off topic · 14 Jun 2026 · 8 likes Practical note on best-written scientific paper: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
-
Documenting a supplier's response to a discrepancy Replied, post #14 · Sourcing › Vendor reports · 13 Jun 2026 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Flagging that the sources on…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #58 · Compounds › Semaglutide · 10 Jun 2026 · 5 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #53 · Clinical › Comorbidities · 7 Jun 2026 · 15 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it. The conclusion is…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #83 · Data & Tools › Calculators · 6 Jun 2026 · 17 likes Narrowing post #82, because the general version has more than one answer. Significant figures in the output should not exceed what the inputs support. A concentration…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #73 · Sourcing › Red flags · 5 Jun 2026 · 23 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. Pressure to pay outside a normal channel is the practical warning that has nothing…
-
When your prescriber and the evidence disagree Replied, post #14 · Clinical › Prescriber conversations · 5 Jun 2026 · 0 likes This follows post #12 rather than contradicting it. The reason prescriber keeps being re-asked is that the answer is conditional and people quote it without the…
-
Documenting a payment dispute without naming and shaming Replied, post #10 · Sourcing › Payments · 4 Jun 2026 · 0 likes This follows post #8 rather than contradicting it. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #17 · Practice › Storage & stability · 6 May 2026 · 6 likes Post #13 describes the usual case. This is about the unusual one. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #11 · Analytics › Impurities & related substances · 4 May 2026 · 26 likes Source for the Endotoxin figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #101 · Practice › Reconstitution · 24 Apr 2026 · 1 like Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Grapefruit: why this class is not the class that cares Replied, post #138 · Practice › Interactions · 9 Apr 2026 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #33 · Evidence › Journal club · 7 Apr 2026 · 7 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #24 · Data & Tools › Calculators · 4 Apr 2026 · 6 likes Post #23 is the version of this I will quote in future. One addition. The most common input error is entering the vial mass in the concentration field. It produces a…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #54 · Practice › Reconstitution · 24 Mar 2026 · 1 like Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #16 · Evidence › Preprints · 23 Mar 2026 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #104 · Lounge › Introductions · 18 Mar 2026 · 31 likes Nice to meet you. Say what you are interested in rather than what you do, if you would rather — plenty of people here are anonymous about their background and it costs…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #10 · Evidence › Journal club · 16 Mar 2026 · 0 likes Post #9 answers the question as asked. The question underneath it is different. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
A fridge failure and how I assessed the contents afterwards Replied, post #4 · Devices › Cold chain · 12 Mar 2026 · 0 likes The opening post answers the question as asked. The question underneath it is different. Shipment during summer or to hot climates: consider shipping to a cold-storage…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #54 · Analytics › Mass spectrometry · 2 Mar 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #46 · Start Here › Welcome · 24 Feb 2026 · 20 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Dead volume across syringe and needle combinations Replied, post #72 · Devices › Syringes & needles · 15 Feb 2026 · 0 likes Taking post #69 at face value and following it one step further. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #44 · Data & Tools › Calculators · 11 Feb 2026 · 17 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Adolescents: a distinct evidence base — one year on Replied, post #61 · Clinical › Special populations · 4 Feb 2026 · 8 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Validating a calculator against hand arithmetic Replied, post #4 · Data & Tools › Calculators · 2 Feb 2026 · 11 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Revisiting: Absolute versus relative contraindications Replied, post #9 · Safety › Contraindications · 16 Jan 2026 · 2 likes The section of the product information covering special warnings is usually longer and more useful than the contraindications list itself.
-
The headache that turns out to be dehydration Replied, post #102 · Nutrition & Training › Hydration & electrolytes · 20 Dec 2025 · 8 likes Where I would push back on the headache consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #28 · Compounds › Retatrutide · 19 Dec 2025 · 8 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
-
About the Method validation category Replied, post #4 · Analytics › Method validation · 3 Dec 2025 · 23 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
When to stop reading forums, including this one Replied, post #57 · Wellbeing › Mental health · 3 Dec 2025 · 0 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology. Not the answer, but possibly the…
-
Prescription requirements and telehealth models Replied, post #42 · Sourcing › Regulatory · 1 Dec 2025 · 2 likes Building on post #39 rather than restating it. The strongest argument against my own position on prescription requirements and telehealth models, stated as well as I…
-
Thyroid function tests during substantial weight change Replied, post #140 · Clinical › Bloodwork · 19 Nov 2025 · 29 likes Checked the thyroid function tests during substantial claim against the primary source this morning. It survives, with a narrower scope than the version quoted here.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #50 · Compounds › Semaglutide · 19 Nov 2025 · 26 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Follow-up: Constipation management, with a dietitian's contribution Started this topic · Practice › Side effects · 7 Oct 2025 · 0 likes Constipation management, with a dietitian's contribution — setting out what I have, and where I think it stops being reliable. A follow-up question about Constipation…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #48 · Pharmacology › Receptor biology · 5 Oct 2025 · 0 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. GLP-1 receptor agonism produces its metabolic effects through more than one route:…
-
Warfarin and altered intake: the monitoring argument Started this topic · Practice › Interactions · 4 Oct 2025 · 43 likes Warfarin and altered intake: the monitoring argument — setting out what I have, and where I think it stops being reliable. Proposing that warfarin and altered intake…
-
Research-use-only labelling: what it means and what it does not Replied, post #39 · Sourcing › Regulatory · 28 Sep 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. Happy to expand any…
-
Which panel is worth repeating and which is worth ignoring Replied, post #119 · Clinical › Bloodwork · 24 Sep 2025 · 2 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Payment method and the leverage it gives you, ranked Replied, post #48 · Sourcing › Payments · 21 Sep 2025 · 11 likes Source for the payment method figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
Second pass at: Programming during a large energy deficit Replied, post #2 · Nutrition & Training › Resistance training · 6 Sep 2025 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Recovery capacity falls with energy availability, so a programme that worked at…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #20 · Compounds › Tirzepatide · 27 Aug 2025 · 9 likes Post #16 and I disagree about the size of the effect, not about the direction. Research-use-only tirzepatide is not approved for human use and is not made to…
-
Interpreting a composition change that is within the error bars Replied, post #22 · Outcomes › Body composition · 27 Jul 2025 · 0 likes Post #18 put the caveat in the right place and I want to underline it. The question underneath interpreting a composition change is usually "how would I tell?" rather…
-
Asking about a compound your prescriber has not heard of Replied, post #107 · Clinical › Prescriber conversations · 27 Jul 2025 · 26 likes Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable. If the premise is…
-
An emergency department visit, described afterwards Replied, post #45 · Safety › Adverse events · 23 Jul 2025 · 11 likes I read post #43 twice before replying, because I had assumed the opposite. Attribution is genuinely hard for a single case and the reporting schemes are designed to…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #72 · Compounds › Semaglutide · 16 Jul 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Comparing my trajectory with the trial curves, carefully Replied, post #23 · Outcomes › Progress reports · 11 Jul 2025 · 15 likes Progress reports that describe an ordinary trajectory are more useful than remarkable ones and are far rarer, because only the remarkable ones feel worth posting.
-
Repeatability versus intermediate precision Replied, post #106 · Analytics › Method validation · 30 Jun 2025 · 0 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #32 · Analytics › Home & field testing · 29 Jun 2025 · 10 likes Thank you for the correction. I would rather find out here than later.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #69 · Access › Insurance & coverage · 11 Jun 2025 · 12 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. Where an exception process exists separately from an appeal, they…
-
Pre-registering a personal experiment, seriously Replied, post #95 · Research Methods › N-of-1 designs · 2 Jun 2025 · 32 likes Pre-registering a personal experiment: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would…
-
Half-life, steady state, and accumulation worked through Replied, post #52 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 26 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #23 · Practice › Dosing & titration · 27 May 2025 · 32 likes Marking my place. If it changes for me I will come back and say so.
-
Follow-up: What other technical communities get right that we do not Replied, post #79 · Lounge › Off topic · 26 Apr 2025 · 25 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. Posted with less confidence than the…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 7 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #44 · Sourcing › Vendor reports · 1 Apr 2025 · 0 likes Narrowing post #43, because the general version has more than one answer. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 14 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #35 · Practice › Reconstitution · 21 Mar 2025 · 19 likes Post #32 and I disagree about the size of the effect, not about the direction. The failure mode on 5 mg vial is boring rather than dramatic. It is almost always the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #91 · Analytics › COA interpretation · 17 Mar 2025 · 1 like Answering the question post #87 raises rather than the one it answers. Reporting rather than recommending, on Counter-ion form. What happened is above. Whether it…
-
Preservatives: function, testing, and limits Replied, post #20 · Pharmacology › Formulation chemistry · 14 Mar 2025 · 0 likes No notes. Posting so the count is not one.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #72 · Analytics › COA interpretation · 11 Mar 2025 · 12 likes Taking post #69 at face value and following it one step further. Purity and content are different measurements: purity tells you what proportion of the detected…
-
Deamidation and the close-eluting pair it produces Replied, post #5 · Analytics › Impurities & related substances · 5 Mar 2025 · 10 likes I read the opening post twice before replying, because I had assumed the opposite. Racemisation produces a diastereomer that is mass-identical and chromatographically…
-
Validating a method you did not develop — does this still hold? Replied, post #59 · Analytics › Method validation · 1 Mar 2025 · 23 likes I came in to disagree and I am leaving without a disagreement.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #23 · Compounds › Semaglutide · 27 Feb 2025 · 0 likes Taking post #20 at face value and following it one step further. Answering the SELECT question as asked, then the question I think is meant. As asked: yes, with the…
-
Canadian access and provincial variation Replied, post #58 · Regional › North America · 5 Feb 2025 · 11 likes Taking post #57 at face value and following it one step further. Trying to state the canadian access and provincial variation position in a way that someone who…
-
A page that has drifted out of date and needs a maintainer Replied, post #54 · Documentation › Wiki requests · 21 Jan 2025 · 31 likes Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is for and it has its own standards. I would want a second…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #84 · Practice › Side effects · 18 Dec 2024 · 28 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #123 · Practice › Dosing & titration · 11 Dec 2024 · 9 likes Confirming post #122 from a second method, which matters more than confirming it from a second person. The failure mode on four-week escalation interval is boring…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #9 · Evidence › Trials · 30 Nov 2024 · 20 likes Narrowing post #8, because the general version has more than one answer. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #138 · Clinical › Bloodwork · 24 Oct 2024 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #30 · Clinical › Comorbidities · 13 Oct 2024 · 9 likes I read the earlier replies on Hypertension improvement twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Requesting a page: what makes a good request — what changed since Replied, post #40 · Documentation › Wiki requests · 10 Oct 2024 · 17 likes Right, and stated more narrowly than I would have dared to state it.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #143 · Nutrition & Training › Hydration & electrolytes · 9 Oct 2024 · 8 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Correlation in a self-tracked dataset: what it can support Replied, post #41 · Research Methods › Statistics · 21 Aug 2024 · 0 likes An update on my earlier correlation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #27 · Analytics › COA interpretation · 14 Aug 2024 · 11 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…